(Q51550980)

6 April 2018

title

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. (English)

1 reference

6 April 2018

0 references

1 reference

chronic heart failure

1 reference

1

William T Abraham

1 reference

6 April 2018

author name string

Philip B Adamson

2

1 reference

6 April 2018

Robert C Bourge

3

1 reference

6 April 2018

Mark F Aaron

4

1 reference

6 April 2018

Maria Rosa Costanzo

5

1 reference

6 April 2018

Lynne W Stevenson

6

1 reference

6 April 2018

Warren Strickland

7

1 reference

6 April 2018

Suresh Neelagaru

8

1 reference

6 April 2018

Nirav Raval

9

1 reference

6 April 2018

Steven Krueger

10

1 reference

6 April 2018

Stanislav Weiner

11

1 reference

6 April 2018

David Shavelle

12

1 reference

6 April 2018

Bradley Jeffries

13

1 reference

6 April 2018

Jay S Yadav

14

1 reference

6 April 2018

CHAMPION Trial Study Group

15

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 February 2011

1 reference

6 April 2018

published in

The Lancet

1 reference

6 April 2018

volume

377

1 reference

6 April 2018

page(s)

658-666

1 reference

6 April 2018

issue

9766

1 reference

6 April 2018

Recent national trends in readmission rates after heart failure hospitalization

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Rehospitalizations among patients in the Medicare fee-for-service program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

The cost of medical management in advanced heart failure during the final two years of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Telemonitoring in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

A wireless pressure sensor for monitoring pulmonary artery pressure in advanced heart failure: initial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: multicentre experience of the monitoring Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal (PAPIRUS) II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Cardiac-resynchronization therapy for the prevention of heart-failure events.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960101-3

7 January 2021

10.1016/S0140-6736(11)60101-3

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

21315441

1 reference

6 April 2018